Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Spero Therapeutics, Inc.

NASDAQ: SPRO · Life Sciences · 5 alerts · CIK 1701108

Share price
$0.9464Close, Nov 16
Market cap
$55.1M
Shares outstanding
58.26MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Spero Therapeutics, Inc. filings on SEC EDGAR ↗

5:31 PM ET 8-K
Leadership Change

Spero Therapeutics Leadership Change

Patrick Vink, M.D. resigned from the Board of Directors effective November 10, 2026, after 11 years of service. To fill the vacancy, the Board appointed William Ho, M.D., Ph.D., a former RAPT Therapeutics executive, as a Class II director and member of the Development Committee. Dr. Ho will receive an annual cash retainer of $45,000 and was granted an option to purchase 100,000 shares of common stock.

5:17 PM ET 8-K
Leadership Change

Spero Therapeutics Leadership Change

Timothy Keutzer, the Chief Operating Officer of Spero Therapeutics, will retire effective December 31, 2026, after 11 years with the company. Following his retirement, he will enter into a consulting arrangement to provide transition advisory services through February 28, 2027.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.